These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26502667)

  • 1. [Draft guideline regarding appropriate use of 131I-MIBG radiotherapy for neuroendocrine tumors Drafting Committee for Guideline of Radiotherapy with 131I-MIBG, Committee for Nuclear Oncology and Immunology, The Japanese Society of Nuclear Medicine].
    Kinuya S; Yoshinaga K; Higuchi T; Jinguji M; Kawamoto H; Kurihara H
    Kaku Igaku; 2015 Feb; 52(1):1-15. PubMed ID: 26502667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Draft guidelines regarding appropriate use of (131)I-MIBG radiotherapy for neuroendocrine tumors : Guideline Drafting Committee for Radiotherapy with (131)I-MIBG, Committee for Nuclear Oncology and Immunology, The Japanese Society of Nuclear Medicine.
    Kinuya S; Yoshinaga K; Higuchi T; Jinguji M; Kurihara H; Kawamoto H;
    Ann Nucl Med; 2015 Jul; 29(6):543-52. PubMed ID: 25773397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Guideline draft of appropriate use of 131I-MIBG for internal radiotherapy of neuroendocrine tumors].
    Nakajo M; Yoshinaga K; Oriuchi N; Kinuya S; Yokoyama K; Yamaguchi T; ; ;
    Kaku Igaku; 2008 Feb; 45(1):suppl 1-40. PubMed ID: 19594094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy of low activity meta-[131I]iodobenzylguanidine therapy in patients with disseminated neuroendocrine tumours depends on initial response.
    Buscombe JR; Cwikla JB; Caplin ME; Hilson AJ
    Nucl Med Commun; 2005 Nov; 26(11):969-76. PubMed ID: 16208174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 131I-MIBG Therapy in a Metastatic Small Bowel Neuroendocrine Tumor Patient Undergoing Hemodialysis.
    Rahimi B; Makis W; Riauka TA; McEwan AJ; Morrish D
    Clin Nucl Med; 2017 May; 42(5):350-353. PubMed ID: 28240668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of 131I-metaiodobenzylguanidine (MIBG) in the treatment of neuroendocrine tumours. Experience of the National Cancer Institute of Milan.
    Castellani MR; Chiti A; Seregni E; Bombardieri E
    Q J Nucl Med; 2000 Mar; 44(1):77-87. PubMed ID: 10932604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects and safety of ¹³¹I-metaiodobenzylguanidine (MIBG) radiotherapy in malignant neuroendocrine tumors: results from a multicenter observational registry.
    Yoshinaga K; Oriuchi N; Wakabayashi H; Tomiyama Y; Jinguji M; Higuchi T; Kayano D; Fukuoka M; Inaki A; Toratani A; Okamoto S; Shiga T; Ito YM; Nakajo M; Nakajo M; Kinuya S; ; ;
    Endocr J; 2014; 61(12):1171-80. PubMed ID: 25214026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential increased tumor-dose delivery with combined 131I-MIBG and 90Y-DOTATOC treatment in neuroendocrine tumors: a theoretic model.
    Madsen MT; Bushnell DL; Juweid ME; Menda Y; O'Dorisio MS; O'Dorisio T; Besse IM
    J Nucl Med; 2006 Apr; 47(4):660-7. PubMed ID: 16595501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EANM procedure guidelines for 131I-meta-iodobenzylguanidine (131I-mIBG) therapy.
    Giammarile F; Chiti A; Lassmann M; Brans B; Flux G;
    Eur J Nucl Med Mol Imaging; 2008 May; 35(5):1039-47. PubMed ID: 18274745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of neuroendocrine tumours in adults with 131I-MIBG therapy.
    Bomanji JB; Wong W; Gaze MN; Cassoni A; Waddington W; Solano J; Ell PJ
    Clin Oncol (R Coll Radiol); 2003 Jun; 15(4):193-8. PubMed ID: 12846498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 131I/123I-metaiodobenzylguanidine (MIBG) scintigraphy: procedure guidelines for tumour imaging.
    Bombardieri E; Aktolun C; Baum RP; Bishof-Delaloye A; Buscombe J; Chatal JF; Maffioli L; Moncayo R; Mortelmans L; Reske SN
    Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):BP132-9. PubMed ID: 14989227
    [No Abstract]   [Full Text] [Related]  

  • 12. Intraarterial 131I-MIBG therapy of neuroendocrine tumors with liver metastases.
    Popp M; Strumpf A; Zöphel K; Stroszczynski C; Kotzerke J
    Nuklearmedizin; 2010; 49(1):N2-3. PubMed ID: 20336828
    [No Abstract]   [Full Text] [Related]  

  • 13. Radioiodinated metaiodobenzylguanidine treatment of neuroendocrine tumors in adults.
    Postema EJ; McEwan AJ
    Cancer Biother Radiopharm; 2009 Oct; 24(5):519-25. PubMed ID: 19877881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of molecular radiotherapy with [131I]-meta Iodobenzylguanidine for high-risk neuroblastoma.
    Gaze MN; Gains JE; Walker C; Bomanji JB
    Q J Nucl Med Mol Imaging; 2013 Mar; 57(1):66-78. PubMed ID: 23474636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orbital Metastases of Neuroendocrine Tumors Treated With 177Lu-DOTATATE PRRT or 131I-MIBG Therapies.
    Makis W; McCann K; McEwan AJ
    Clin Nucl Med; 2016 Feb; 41(2):137-41. PubMed ID: 26447382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of radiohaloanalogues of meta-iodobenzylguanidine (MIBG) for a combined gene- and targeted radiotherapy approach to bladder carcinoma.
    Fullerton NE; Boyd M; Ross SC; Pimlott SL; Babich J; Kirk D; Zalutsky MR; Mairs RJ
    Med Chem; 2005 Nov; 1(6):611-8. PubMed ID: 16787344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical applications of dosimetry for mIBG therapy.
    Flux GD; Chittenden SJ; Saran F; Gaze MN
    Q J Nucl Med Mol Imaging; 2011 Apr; 55(2):116-25. PubMed ID: 21386786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient dosimetry for 131I-MIBG therapy for neuroendocrine tumours based on 123I-MIBG scans.
    Monsieurs M; Brans B; Bacher K; Dierckx R; Thierens H
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1581-7. PubMed ID: 12458391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-[131I]iodobenzylguanidine in the scintigraphic evaluation of neural crest tumors.
    Zagar I; Han R; Mitrovic S
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):13-6. PubMed ID: 9002742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated Radionuclide therapy in metastatic paraganglioma leading to the highest reported cumulative activity of 131I-MIBG.
    Ezziddin S; Sabet A; Ko YD; Xun S; Matthies A; Biersack HJ
    Radiat Oncol; 2012 Jan; 7():8. PubMed ID: 22277577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.